InvestorsHub Logo
Followers 70
Posts 2498
Boards Moderated 0
Alias Born 08/11/2017

Re: knrorrel post# 36697

Monday, 08/05/2019 12:21:47 PM

Monday, August 05, 2019 12:21:47 PM

Post# of 71147
$LAHO ..Regenerative Medicine RM) Industry..rapidly expanding in recent years, making it a high-value, fast-growth market..Big Pharma is also demonstrating a snowballing interest in regenerative medicine.
The Regenerative Medicine (RM) Industry includes companies that are developing:

Stem cell therapies
Cellular therapies
Gene therapies
Tissue engineering
Direct cell reprogramming
Exosome therapies
Cellular scaffolds and matrices
3D bioprinting
Biomaterials
Combination Products
And More

https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html



..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/

3D Bioprinting Market To Reach USD 4.40 Billion

.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.


https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html

$LAHO GSCG


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.